Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer.
Boerrigter E, Overbeek JK, Benoist GE, Somford DM, Hamberg P, Tol J, Scholtes B, Willemsen AECAB, Buffart LM, Kessels RPC, Mehra N, van Oort IM, van Erp NP. Boerrigter E, et al. Among authors: van erp np. Eur Urol Oncol. 2024 Mar 13:S2588-9311(24)00057-9. doi: 10.1016/j.euo.2024.02.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38485614 Free article.
The Combination of Enzalutamide and Opioids: A Painful Pitfall?
Benoist GE, van Oort IM, Burger DM, Koch BCP, Mehra N, van Erp NP. Benoist GE, et al. Among authors: van oort im, van erp np. Eur Urol. 2019 Feb;75(2):351-352. doi: 10.1016/j.eururo.2018.09.011. Epub 2018 Sep 21. Eur Urol. 2019. PMID: 30245086 No abstract available.
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide.
Benoist GE, Hendriks RJ, Mulders PF, Gerritsen WR, Somford DM, Schalken JA, van Oort IM, Burger DM, van Erp NP. Benoist GE, et al. Among authors: van oort im, van erp np. Clin Pharmacokinet. 2016 Nov;55(11):1369-1380. doi: 10.1007/s40262-016-0403-6. Clin Pharmacokinet. 2016. PMID: 27106175 Free PMC article. Review.
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
Benoist GE, van Oort IM, Smeenk S, Javad A, Somford DM, Burger DM, Mehra N, van Erp NP. Benoist GE, et al. Among authors: van oort im, van erp np. Br J Clin Pharmacol. 2018 Jan;84(1):122-129. doi: 10.1111/bcp.13425. Epub 2017 Oct 18. Br J Clin Pharmacol. 2018. PMID: 28881501 Free PMC article.
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate Cancer.
Benoist GE, van der Meulen E, van Oort IM, Beumer JH, Somford DM, Schalken JA, Burger DM, van Erp NP. Benoist GE, et al. Among authors: van oort im, van der meulen e, van erp np. Ther Drug Monit. 2018 Apr;40(2):222-229. doi: 10.1097/FTD.0000000000000484. Ther Drug Monit. 2018. PMID: 29419723 Free PMC article.
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.
Lubberman FJE, Benoist GE, Gerritsen W, Burger DM, Mehra N, Hamberg P, van Oort I, van Erp NP. Lubberman FJE, et al. Among authors: van oort i, van erp np. Cancer Chemother Pharmacol. 2019 Dec;84(6):1179-1185. doi: 10.1007/s00280-019-03952-w. Epub 2019 Sep 12. Cancer Chemother Pharmacol. 2019. PMID: 31515667 Free PMC article. Clinical Trial.
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Benoist GE, van Oort IM, Boerrigter E, Verhaegh GW, van Hooij O, Groen L, Smit F, de Mol P, Hamberg P, Dezentjé VO, Mehra N, Gerritsen W, Somford DM, van Erp NPH, Schalken JA. Benoist GE, et al. Clin Chem. 2020 Jun 1;66(6):842-851. doi: 10.1093/clinchem/hvaa095. Clin Chem. 2020. PMID: 32408351
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.
Boerrigter E, Benoist GE, van Oort IM, Verhaegh GW, van Hooij O, Groen L, Smit F, Oving IM, de Mol P, Smilde TJ, Somford DM, Mehra N, Schalken JA, van Erp NP. Boerrigter E, et al. Among authors: van hooij o, van oort im, van erp np. Mol Oncol. 2021 Sep;15(9):2453-2465. doi: 10.1002/1878-0261.12933. Epub 2021 May 29. Mol Oncol. 2021. PMID: 33650292 Free PMC article.
123 results